Omeprazole acetaminophen
Pro Research Analysisby 
Searched over 200M research papers for "omeprazole acetaminophen"
The Interaction Between Omeprazole and Acetaminophen Metabolism
Introduction to Omeprazole and Acetaminophen
Omeprazole is a widely used proton pump inhibitor (PPI) that reduces stomach acid production by inhibiting the H+/K+-ATPase enzyme in the stomach lining. It is commonly prescribed for conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers. Acetaminophen, also known as paracetamol, is a popular analgesic and antipyretic agent used to treat pain and fever. However, at high doses, acetaminophen can cause serious liver and kidney toxicity due to its conversion to the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) through the cytochrome P450 (CYP) enzyme system.
Omeprazole's Effect on Cytochrome P450 Enzymes
Omeprazole has been shown to induce certain cytochrome P450 enzymes, particularly CYP1A2, which plays a role in the metabolism of various drugs, including acetaminophen. This induction is more pronounced in individuals who are slow metabolizers of S-mephenytoin, a substrate of CYP2C19, another enzyme involved in drug metabolism 13. Despite this induction, studies have shown that omeprazole does not significantly alter the metabolism of acetaminophen in humans or animals.
Human Studies on Omeprazole and Acetaminophen Metabolism
A study investigating the effect of omeprazole pretreatment on acetaminophen metabolism in both rapid and slow metabolizers of S-mephenytoin found that, despite a 75% increase in CYP1A2 activity, there was no significant increase in the formation of the toxic metabolite NAPQI from acetaminophen after 7 days of omeprazole administration 13. This suggests that the induction of CYP1A2 by omeprazole is unlikely to increase the risk of acetaminophen-induced hepatotoxicity.
Animal Studies on Omeprazole and Acetaminophen Kinetics
In a study conducted on rats, omeprazole administration did not affect the pharmacokinetic parameters of acetaminophen, including its elimination rate constant, half-life, clearance, and volume of distribution . This further supports the conclusion that omeprazole does not significantly impact acetaminophen metabolism and does not increase susceptibility to acetaminophen toxicity.
Broader Implications of Omeprazole and Cytochrome P450 Interactions
Concerns have been raised about the potential for omeprazole to increase the toxicity of acetaminophen through the induction of CYP1A2. However, these concerns appear to be unfounded. Stronger inducers of CYP1A2, such as cigarette smoke and charcoaled beef, do not alter acetaminophen metabolism, suggesting that the induction of this enzyme by omeprazole is unlikely to have a significant impact 456. Additionally, the induction of CYP1A2 by omeprazole is relatively minor and does not lead to significant changes in the metabolism of other drugs metabolized by this enzyme 45.
Conclusion
Overall, the available evidence indicates that omeprazole does not significantly affect the metabolism of acetaminophen or increase the risk of acetaminophen-induced hepatotoxicity. Both human and animal studies support the conclusion that the induction of CYP1A2 by omeprazole is not sufficient to alter acetaminophen metabolism in a clinically relevant manner. Therefore, concerns about the potential adverse effects of omeprazole on acetaminophen toxicity are not supported by experimental evidence.
Sources and full results
Most relevant research papers on this topic